A full-time position as Professor of Immunology is available at the Faculty of Medicine, Lund University. For more information, please click here: ledigkungörelse 200601.
Applications are invited from enthusiastic post-doctoral candidates to participate in a project supported by the French National Agency (ANR), 2-year position – possible extension. The research program centers on the innate immune response against viral infection.
For information on the position, please click here: Post doc position innate immunity CIRI.
Professor of Translational Immunology
A permanent full-time position as Professor of Translational Immunology is vacant at the Faculty of Medicine, Broegelmann Research Laboratory, and the Department of Clinical Science. The place of work is in the Laboratory Building at Haukeland University Hospital, in Bergen, Norway.
Broegelmann Research Laboratory is an immunological research unit organized within The Department of Clinical Science, and located in the Laboratory Building. The unit has traditionally worked with basic and translational projects related to diseases in the immune system including autoimmun disorders in collaboration with clinical departments at the hospital.
The Department of Clinical Science is one of two clinical departments at the Faculty of Medicine and covers several of the clinical disciplines within the field of medicine. There are about 350 employees at the Department of Clinical Science which is located in the Laboratory Building, Haukeland University Hospital campus. The Department of Clinical Science has medical research, supervision and teaching on a high international level. The department has important tasks in the training of new doctors, master degree programs, and PhD education within medicine, dentistry, pharmacy and nutrition.
About the work tasks/research:
The successful applicant shall lead the Broegelmann Research Laboratory (BRL) (http://www.uib.no/rg/broegelmann). In addition, the laboratory also runs the thematically focused Bergen Research School in Inflammation (http://www.uib.no/en/rs/brsi).
The successful candidate must have his/her research activity within translational immunology or similar research area. The research activity must be relevant for the activity at Broeglemann Research Laboratory.
The basic funding of BRL (approx. 3 mills NOK annually) comes from the Broegelmann Foundation. Currently this funding covers salary support for two technical staff and one administrative position. In addition, support is provided to one PhD fellowship plus support for consumables. However, it is expected that the successful candidate has experience and abilities to obtain additional national and international funding through the Norwegian Research Council, EU, etc.
Qualifications and personal qualities:
The applicant should by preference have an MD degree and must have a relevant Norwegian doctorate (PhD) or corresponding qualifications
- the successful candidate will be teaching in both innate and adaptive immunology
- the successful candidate will also supervise Master- and PhD-candidates
- emphasis will be put on the applicant’s ability to create a good research environment within own national and international networks
- emphasis will be put on the ability to achieve external funding
- basic teaching training is a requirement, both formally education and teaching experience. It is important to enclose documentation of courses etc. and teaching skills, ref. Rules for assessing educational competence at UiB.
- the teaching language will normally be Norwegian. The successful applicant must be able to teach in Norwegian or one of the other Scandinavian languages within two years of his/her appointment. Norwegian courses will be offered
Experience as leader of research projects, coordinating research activities, and strategic work will be highly regarded, also willingness and ability to work in a team will be emphasized.
We can offer:
- a good and challenging international working environment in a faculty with an academic environment that is in the forefront nationally and internationally
- professional challenges with opportunities for personal development and skills development
- salary in accordance with level 77-79 (code 1013) on the government salary scale, at present NOK 741 300 – 789 200 gross p.a. for a full-time position. In the case of a highly qualified candidate, a higher salary may be considered
- enrolment in the Norwegian Public Service Pension Fund
- good welfare benefits
Your application must include:
- CV, scanned copies of your certificates
- evidence of teaching qualifications both formally education and teaching experience (educational directory)
- complete list of scholarly works, with information about where these have been published
- list of works on which the committee should place special emphasis in its evaluation with information on where they have been published
- scholarly works, or parts of such works on which the committee should place special emphasis in its evaluation (max 15)
- two referees (names and contact information)
It is very important that each of the scholarly works on which the committee should place special emphasis, is attached in its entirety.
In addition, we ask the applicant to upload the following:
● documentation of external fund raising
● research plan for the next five years (maximum five pages)
General information:
Additional information on the position is obtainable from Head of Department of Clinical Science, professor Pål R. Njølstad (Pal.Njolstad@uib.no)
The state workforce shall reflect the diversity of Norwegian society to the greatest extent possible. People with immigrant backgrounds and people with disabilities are encouraged to apply for the position.
We encourage women to apply. If multiple applicants have approximately equivalent qualifications, the rules pertaining to moderate gender quotes shall apply.
Please also refer to: https://www.jobbnorge.no/en/available-jobs/job/188809/professor-translational-immunology
We are seeking a POSTDOCTORAL RESEARCH ASSOCIATE to join the collaborative research group of Dr. Jeffrey D. Cirillo studying respiratory pathogenesis. Responsibilities include conducting independent research on SARS-CoV-2, mycobacterial and other respiratory pathogens and publication of results. Research will emphasize the molecular, cell biological, live animal molecular imaging and immunological characterization of virulence determinants in respiratory pathogens and their interactions with the host in humans, mice and guinea pigs.
Interested applicants should apply at the following link: https://tamus.wd1.myworkdayjobs.com/TAMHSC_External/job/Bryan-TAMHSC/Postdoctoral-Research-Associate_R-029969-1. You will need to upload current Curriculum Vitae, cover letter, and three reference letters written to Dr. Jeffrey D. Cirillo.
Applicants should also have a record of productive experience in immunology, chemistry, biochemistry, molecular biology of pathogens, outstanding interpersonal skills, and excellent written and verbal communication. Responsibilities include: conducting independent research on SARS-CoV-2, mycobacterial and other respiratory pathogens and publication of results, assistance with preparation of manuscripts, grants, and publications of scientific data in peer-revised journals based on research, and assisting other members of the research team as needed. Lab members are also required to attend laboratory meetings, departmental seminars and journal club.
Applicants must have a Ph.D. or terminal professional degree (D.V.M. and/or M.D).
Texas A&M Health Science Center is an equal opportunity/affirmative action/Veterans/Disability Employer.
An open position as Professor of Experimental Immunology is available at Uppsala University, Sweden.
For more information, please click here: Annons Eng. Professor of Experimental Immunology.
For more information, please click here.
19. February 2020 – 21. February 2020
19 – 21 February 2020
Wellcome Genome Campus, UK
The conference will explore and discuss various aspects of the non-specific effects of vaccines, including their impact on neonates and infants, how generalisable and durable these effects are, the implications for geriatric and veterinary medicine, and why non-specific effects should differ between sexes and across the lifespan.
For more information: Optimmunize_2019_A4_Poster
And: Conference website
On Monday, December 9th, Søren Degn will host a seminar given by Valentyn Oksenych, PhD,
group leader at Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.
The title of this I&I International Seminar is:
“New factors required for lymphocyte development: in vivo models”
Venue: Merete Barker Auditorium, (Bldg. 1253-211 / Lake side lecture theatres)
Time: 10:00-11:00am
Abstract:
Development of B and T lymphocytes depends on the DNA breaks and repair events known as V(D)J recombination. There are two molecular pathways involved in the DNA repair during the lymphocyte development, non-homologous end joining (NHEJ) and DNA damage response (DDR). Recently, new accessory NHEJ factors PAXX and Mri were reported. Deficiency for PAXX or Mri, however, had no obvious effect on the lymphocyte development. Applying genetic models, we found that PAXX and Mri are functionally redundant with another NHEJ factor, XLF. Moreover, combined deficiency for XLF/PAXX and XLF/Mri results in dramatic, although distinct, phenotypes. In addition, we found that multiple factors from the DDR pathway are required for specific stages of B cell development.
INVITATION TO PhD DEFENCE
Broadening the T cell response against hepatitis C
virus by vaccination with peptides in cationic
particles
by Jonathan Filskov
Copenhagen Hepatitis C Program (CO-HEP)
Department of Infectious Diseases, Hvidovre Hospital
Department of Immunology and Microbiology, Faculty of Health
and Medical Sciences, University of Copenhagen
and
Department of Infectious Disease Immunology, Statens Serum Institut (SSI)
November 25, 2019 at 14:00
Auditorium 3+4, Hvidovre Hospital
Kettegård Allé 30, 2650 Hvidovre
For more info PhD defence invitation_Jonathan Filskov_Final.
Deadline: Oct 31st.
For more information: click here.